ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,462 | -91.8% | 2,891 | -89.1% | 0.01% | -53.8% |
| Q1 2023 | $958,830 | -8.8% | 26,612 | 0.0% | 0.01% | -18.8% |
| Q4 2022 | $1,051,706 | -99.9% | 26,612 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $1,069,270,000 | +47.1% | 26,612 | +53.9% | 0.02% | +77.8% |
| Q2 2022 | $726,956,000 | -0.6% | 17,292 | -7.8% | 0.01% | +12.5% |
| Q1 2022 | $731,006,000 | -37.8% | 18,763 | -36.4% | 0.01% | -33.3% |
| Q4 2021 | $1,174,858,000 | +9.3% | 29,482 | -0.8% | 0.01% | +9.1% |
| Q3 2021 | $1,074,587,000 | +34.5% | 29,734 | +52.5% | 0.01% | +37.5% |
| Q2 2021 | $798,977,000 | -7.7% | 19,492 | +12.7% | 0.01% | -20.0% |
| Q4 2020 | $865,465,000 | – | 17,292 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |